Full Text View
Tabular View
No Study Results Posted
Related Studies
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
This study is currently recruiting participants.
Verified January 2013 by National Institutes of Health Clinical Center (CC)
Study NCT01195922   Information provided by National Institutes of Health Clinical Center (CC)

First Received on September 3, 2010.   Last Updated on March 29, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mouth Neoplasms
Head and Neck Neoplasms
Tongue Neoplasms
Carcinoma, Squamous Cell
Additional conditions recognized in this trial
Carcinoma
Neoplasms
More general conditions related to this trial
Mouth Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Stomatognathic Diseases
Tongue Diseases
Interventions listed in this trial
Rapamycin
Biopsy
Dynamic CT Perfusion
Positron Emission Tomography
Measurement Serum Cytokines
Additional drug interventions recognized in this trial
Everolimus
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Dental and Craniofacial Research (NIDCR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services